Schizophrenia News

Adjunctive use of daily sodium benzoate did not appear effective as early psychosis treatment, according to results of a randomized clinical trial published in JAMA Network Open.

Long-acting injectable antipsychotics benefit certain patients and should be included in the treatment of schizophrenia, according to a presenter at the NEI Max virtual conference.

A cohort of adults with schizophrenia in Israel had a higher rate of hypothyroidism after diagnosis than controls without schizophrenia, although no difference was found before diagnosis between the two groups, according to study data.

Individuals who were recently diagnosed with a mental disorder were at increased risk for COVID-19 infection, especially African Americans and women, according to study results published in World Psychiatry.

Parental overprotective tendencies appeared associated with hindered recovery among offspring with schizophrenia, according to study results published in PLOS One.

Mental health professionals can implement specific practices in routine clinical care to effectively prescribe clozapine for treatment-resistant schizophrenia, according to a presenter at the American Psychiatric Nurses Annual Conference.

The National Alliance on Mental Illness has designated this week as Mental Illness Awareness Week.

Healio Psychiatry has compiled a list of its five most-viewed stories in September.

The NIH this week announced the launch of Accelerating Medicine Partnership Schizophrenia, according to an institutional press release.

Clinicians must make important considerations regarding the use of psychotropic medications and substances among pregnant women, according to a presenter at the Psych Congress 2020 Virtual Experience conference.